Zhang Chi, Wang Qing, Liu An-Qi, Zhang Chu, Liu Lan-Hao, Lu Long-Feng, Tu Jiagang, Zhang Yong-An
State Key Laboratory of Agricultural Microbiology, College of Fisheries, Huazhong Agricultural University, Wuhan, China.
Pearl River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Guangzhou, China.
Dev Comp Immunol. 2022 Apr;129:104335. doi: 10.1016/j.dci.2021.104335. Epub 2021 Dec 17.
Since emerged in the late 1990s, cyprinid herpesvirus 3 (CyHV-3) has caused huge economic losses in common and koi carp culture worldwide. Accumulating evidences suggest that teleost fish microRNA (miRNA), a class of non-coding RNA of ∼22 nucleotides, can participate in many cellular processes, especially in host antiviral defenses. However, the roles of miRNAs in CyHV-3 infection are still unclear. Here, using high-throughput miRNA sequencing and quantitative real-time PCR (qRT-PCR) verification, we found that miR-155 was significantly upregulated in common carp brain (CCB) cells upon CyHV-3 infection. Overexpression of miR-155 effectively inhibited CyHV-3 replication in CCB cells and promoted type I interferon (IFN-I) expression. Further study revealed that miR-155 targeted the 3' untranslated region (UTR) of the mRNA of 5'AMP-activated protein kinase (AMPK), and that AMPK could interact with and degrade the mitochondrial antiviral signaling protein (MAVS), resulting in the reduction of interferon (IFN) expression. Collectively, our results show that miR-155, induced by CyHV-3 infection, exhibits anti-CyHV-3 activity via regulating AMPK-MAVS-IFN axis, which will help design anti-CyHV-3 drugs.
鲤疱疹病毒3型(CyHV-3)自20世纪90年代末出现以来,已在全球范围内的鲤科鱼类和锦鲤养殖中造成了巨大的经济损失。越来越多的证据表明,硬骨鱼微小RNA(miRNA),一类约22个核苷酸的非编码RNA,可参与许多细胞过程,尤其是宿主抗病毒防御。然而,miRNA在CyHV-3感染中的作用仍不清楚。在此,我们通过高通量miRNA测序和定量实时PCR(qRT-PCR)验证发现,CyHV-3感染后,鲤脑(CCB)细胞中的miR-155显著上调。miR-155的过表达有效抑制了CCB细胞中CyHV-3的复制,并促进了I型干扰素(IFN-I)的表达。进一步研究表明,miR-155靶向5'AMP激活蛋白激酶(AMPK)mRNA的3'非翻译区(UTR),且AMPK可与线粒体抗病毒信号蛋白(MAVS)相互作用并使其降解,从而导致干扰素(IFN)表达减少。总体而言,我们的结果表明,CyHV-3感染诱导的miR-155通过调节AMPK-MAVS-IFN轴表现出抗CyHV-3活性,这将有助于设计抗CyHV-3药物。